Domperidone for Treating Patients with Gastrointestinal Motility Disorders
Study on Oral Treatment for Gastroparesis Symptoms
Brief description of study.
The purpose of this study is to provide oral domperidone to patients more than 18 years of age where according to the physician, this medicine is needed for the relief of symptoms of gastroparesis and other upper GI symptoms, that are not responding to other methods of treatment.
Detailed description of study
The purpose of this study is to provide oral domperidone to patients more than 18 years of age where according to the physician, this medicine is needed for the relief of symptoms of gastroparesis and other upper GI symptoms, that are not responding to other methods of treatment.
Eligibility of study
You may be eligible for this study if you meet the following criteria:
- Conditions: gastroparesis
-
Age: 100 years or below
-
Gender: All
This study investigates the use of an investigational medication for adults experiencing symptoms of gastroparesis and other upper gastrointestinal (GI) issues. Gastroparesis is a condition where the stomach takes too long to empty its contents, leading to symptoms such as nausea and bloating. The study aims to provide this medication to patients who have not found relief from other treatments.
Participants will take the investigational medication orally. The study will monitor their symptoms to determine the effectiveness of the treatment. This involves regular check-ins with the healthcare team to assess any changes in symptoms.
- Who can participate: Adults over the age of 18 who have been diagnosed with gastroparesis or upper GI symptoms that do not respond to other treatments are eligible to participate.
- Study details: Participants will be monitored by the healthcare team to assess the medication's effectiveness.
Interested in the study?
Select a study center that’s convenient for you, and get in touch with the study team.
Please choose between Voice or SMS based delivery of verification code
or